Aortic valve replacement in a patient with sickle cell disease-Are we justified to perform surgery in the TAVI era?
Ramanish RavishankarLeenah TurkistaniYasser ElghoneimyImthiaz ManolyPublished in: Clinical case reports (2021)
Not all variants of SCD need the same management and this should be decided on a case-by-case basis. Heterozygous SCD patients can undergo cardiac surgery without the need for intraoperative exchange transfusions with good clinical outcomes.
Keyphrases
- aortic valve replacement
- aortic stenosis
- transcatheter aortic valve implantation
- ejection fraction
- aortic valve
- cardiac surgery
- end stage renal disease
- minimally invasive
- transcatheter aortic valve replacement
- newly diagnosed
- chronic kidney disease
- prognostic factors
- case report
- coronary artery bypass
- gene expression
- left ventricular
- coronary artery disease